Albinism natural history, complications and prognosis

Jump to navigation Jump to search

Albinism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Albinism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Albinism natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Albinism natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Albinism natural history, complications and prognosis

CDC on Albinism natural history, complications and prognosis

Albinism natural history, complications and prognosis in the news

Blogs on Albinism natural history, complications and prognosis

Directions to Hospitals Treating Albinism

Risk calculators and risk factors for Albinism natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

The complications of albinism include skin cancer, sunburn, decreased visual acuity, poor self-image and self-isolation lead to depression. Patients with albinism has a normal life expectancy and do not have developmental delay or mental retardation.

Complications

Prognosis

References

  1. Mabula JB, Chalya PL, Mchembe MD, Jaka H, Giiti G, Rambau P; et al. (2012). "Skin cancers among Albinos at a University teaching hospital in Northwestern Tanzania: a retrospective review of 64 cases". BMC Dermatol. 12: 5. doi:10.1186/1471-5945-12-5. PMC 3483204. PMID 22681652.
  2. Mapurisa G, Masamba L (2010). "Locally advanced skin cancer in an albino: a treatment dilemma". Malawi Med J. 22 (4): 122–3. doi:10.4314/mmj.v22i4.63949. PMC 3345774. PMID 21977833.
  3. Marçon CR, Maia M (2019). "Albinism: epidemiology, genetics, cutaneous characterization, psychosocial factors". An Bras Dermatol. 94 (5): 503–520. doi:10.1016/j.abd.2019.09.023. PMC 6857599 Check |pmc= value (help). PMID 31777350.
  4. Preston DS, Stern RS (1992). "Nonmelanoma cancers of the skin". N Engl J Med. 327 (23): 1649–62. doi:10.1056/NEJM199212033272307. PMID 1435901.
  5. Bridge H, von dem Hagen EA, Davies G, Chambers C, Gouws A, Hoffmann M; et al. (2014). "Changes in brain morphology in albinism reflect reduced visual acuity". Cortex. 56: 64–72. doi:10.1016/j.cortex.2012.08.010. PMID 23039995.
  6. "Albinism - StatPearls - NCBI Bookshelf".

Template:WS Template:WH